BNA Santé: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
BNA Santé
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€398,660
2024 · €11,821+€386,839
Equity
€892,886
2024 · €670,697+€222,189
Cash
€146,079
2024 · €124,398+€21,681
Balance sheet total
€8.5m
2024 · €7.7m+€793,226
Largest movements
Assets
- Receivables within one year +€666,805
up €666,805 (+119%), from €562,198 to €1.2m
of which Other amounts receivable: +€663,406
- Financial fixed assets +€105,000
up €105,000 (+1.6%), from €6.6m to €6.8m
Equity and liabilities
- Other debts +€625,419
up €625,419 (+230%), from €271,810 to €897,229
- Debts after one year -€247,223
down €247,223 (-3.9%), from €6.4m to €6.1m
of which Financial debts: -€247,223
- Profit (loss) carried forward +€222,189
up €222,189 (+33.3%), from €667,697 to €889,886
- Tax, wage and social debts +€94,900
up €94,900 (+770%), from €12,332 to €107,233
of which Taxes: +€91,261
Income statement
- Gross operating margin +€570,830
up €570,830 (+142%), from €403,041 to €973,871
- Taxes +€132,318
new in 2025: €132,318
- Write-downs +€96,728
up €96,728, from -€96,728 to €0
- Financial charges +€88,172
up €88,172 (+63.6%), from €138,696 to €226,868
- Staff costs -€30,154
down €30,154 (-17.3%), from €174,344 to €144,190
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€11,821
Gross operating margin
+€570,830
Staff costs
+€30,154
Depreciation
-€4,726
Write-downs
-€96,728
Other operating charges
+€1,496
Other operating items
+€108,793
Financial income
-€2,491
Financial charges
-€88,172
Taxes
-€132,318
Result 2025
€398,660
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€585,943
Investment
-€211,430
Financing
-€352,832
Cash 2024
€124,398
From operations (derived)
+€585,943
Net result for the year
+€398,660
Depreciation
+€68,660
Stocks and contracts
+€32,647
Receivables within one year
-€666,805
Deferred charges and accrued income
+€5,384
Trade debts
+€26,078
Tax, wage and social debts
+€94,900
Smaller working-capital items
+€1,001
Other debts
+€625,419
Investment (derived)
-€211,430
Investment in fixed assets (net)
-€211,430
Financing
-€352,832
Debts after one year
-€247,223
Current portion of long-term debt
+€70,861
Contributions, distributions and other
-€176,471
Cash 2025
€146,079
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €7,691,012 | €8,484,238 | +€793,226 | +10.3% |
| Fixed assets | 21/28 | €6,885,246 | €7,028,016 | +€142,770 | +2.1% |
| Tangible fixed assets | 22/27 | €235,646 | €273,416 | +€37,770 | +16.0% |
| Land and buildings | 22 | €35,955 | €30,679 | -€5,277 | -14.7% |
| Plant, machinery and equipment | 23 | €0 | - | = | |
| Furniture and vehicles | 24 | €199,690 | €242,737 | +€43,047 | +21.6% |
| Financial fixed assets | 28 | €6,649,600 | €6,754,600 | +€105,000 | +1.6% |
| Current assets | 29/58 | €805,766 | €1,456,222 | +€650,455 | +80.7% |
| Stocks and contracts in progress | 3 | €107,383 | €74,736 | -€32,647 | -30.4% |
| Stocks | 30/36 | €107,383 | €74,736 | -€32,647 | -30.4% |
| Amounts receivable within one year | 40/41 | €562,198 | €1,229,003 | +€666,805 | +119% |
| Trade receivables | 40 | €66,128 | €69,527 | +€3,399 | +5.1% |
| Other amounts receivable | 41 | €496,070 | €1,159,475 | +€663,406 | +134% |
| Cash at bank and in hand | 54/58 | €124,398 | €146,079 | +€21,681 | +17.4% |
| Deferred charges and accrued income | 490/1 | €11,788 | €6,404 | -€5,384 | -45.7% |
| Total equity and liabilities | 10/49 | €7,691,012 | €8,484,238 | +€793,226 | +10.3% |
| Equity | 10/15 | €670,697 | €892,886 | +€222,189 | +33.1% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €667,697 | €889,886 | +€222,189 | +33.3% |
| Amounts payable | 17/49 | €7,020,315 | €7,591,352 | +€571,037 | +8.1% |
| Amounts payable after more than one year | 17 | €6,369,547 | €6,122,325 | -€247,223 | -3.9% |
| Financial debts | 170/4 | €6,019,547 | €5,772,325 | -€247,223 | -4.1% |
| Other amounts payable | 178/9 | €350,000 | €350,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €632,134 | €1,449,898 | +€817,763 | +129% |
| Current portion of amounts payable after more than one year | 42 | €287,173 | €358,034 | +€70,861 | +24.7% |
| Trade debts | 44 | €60,135 | €86,213 | +€26,078 | +43.4% |
| Suppliers | 440/4 | €60,135 | €86,213 | +€26,078 | +43.4% |
| Advances received on contracts in progress | 46 | €684 | €1,189 | +€505 | +73.8% |
| Taxes, remuneration and social security | 45 | €12,332 | €107,233 | +€94,900 | +770% |
| Taxes | 450/3 | €109 | €91,370 | +€91,261 | +83,918% |
| Remuneration and social security | 454/9 | €12,224 | €15,863 | +€3,639 | +29.8% |
| Other amounts payable | 47/48 | €271,810 | €897,229 | +€625,419 | +230% |
| Accrued charges and deferred income | 492/3 | €18,633 | €19,129 | +€496 | +2.7% |
| Remuneration, social security and pensions | 62 | €174,344 | €144,190 | -€30,154 | -17.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €63,935 | €68,660 | +€4,726 | +7.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€96,728 | €0 | +€96,728 | |
| Other operating charges | 640/8 | €4,682 | €3,185 | -€1,496 | -32.0% |
| Non-recurring operating charges | 66A | €108,793 | €0 | -€108,793 | -100% |
| Gross operating margin | 9900 | €403,041 | €973,871 | +€570,830 | +142% |
| Operating profit (loss) | 9901 | €148,016 | €757,836 | +€609,819 | +412% |
| Financial income | 75/76B | €2,500 | €10 | -€2,491 | -99.6% |
| Recurring financial income | 75 | €2,500 | €10 | -€2,491 | -99.6% |
| Financial charges | 65/66B | €138,696 | €226,868 | +€88,172 | +63.6% |
| Recurring financial charges | 65 | €138,696 | €226,868 | +€88,172 | +63.6% |
| Profit (loss) for the period before taxes | 9903 | €11,821 | €530,977 | +€519,157 | +4,392% |
| Income taxes | 67/77 | - | €132,318 | +€132,318 | |
| Profit (loss) for the period | 9904 | €11,821 | €398,660 | +€386,839 | +3,273% |
| Profit (loss) for the period to be appropriated | 9905 | €11,821 | €398,660 | +€386,839 | +3,273% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.